Form 4: Eli Lilly Executive Acquires Shares

Eli Lilly & Co. EVP, President LLY Imm, Adrienne S Brown, acquired 1,196.308 shares of common stock in a pre-planned transaction.

Summary

• Adrienne S Brown, Executive Vice President and President of LLY Imm at Eli Lilly & Co. (LLY), acquired 1,196.308 shares of common stock.
• The transaction occurred on February 9, 2026, at a price of $1,044.67 per share.
• This acquisition was made pursuant to a Rule 10b5-1(c) pre-planned contract, instruction, or written plan.
• Following this transaction, Adrienne S Brown beneficially owns a total of 4,921.308 shares of Eli Lilly & Co. common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal. An executive's decision to increase their stake, especially through a pre-planned acquisition, suggests confidence in the company's long-term prospects.

Positives

• A high-level executive acquiring additional shares signals confidence in the company's future prospects and valuation.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-meditated investment decision rather than a reactive one.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance, but rather reports a past insider transaction.

Industry Context

StockSavvy.ai notes that insider buying, particularly by a senior executive, is often interpreted by the market as a positive signal, reflecting management's belief in the company's intrinsic value and future growth potential within the pharmaceutical industry.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator of management's belief in the company's value, potentially boosting investor confidence.

Key Dates

Recommendation

The acquisition of shares by a high-ranking executive, particularly under a Rule 10b5-1 plan, demonstrates strong insider confidence in Eli Lilly's future performance and valuation. This positive signal suggests that the stock may be a favorable investment, warranting a 'buy' recommendation for investors looking for companies with strong internal conviction.

Keywords

Eli Lilly, LLY, Insider Trading, Form 4, Stock Purchase, Executive Compensation, Adrienne S Brown, Pharmaceuticals